ADC Manufacturing: Operating Modes, Resulting Design and Technology Choices
Webinar
This webinar highlights how intentional operating modes and enabling technologies address ADC manufacturing challenges, including solvent-containing streams and containment needs, to support safe, robust, and scalable conjugation and purification processes.
In this webinar you will learn:
- Understand key challenges in ADC manufacturing.
- Learn how to intentionally pair operating modes with suitable technology choices for safer ADC production.
- Explore single-use solution considerations and limitations in conjugation and purification workflows.
Speakers
Sarah Le Merdy
Merck
Customer Application Consultant - ADC EMEA
Sarah holds a degree in biochemistry engineering from the National Institute of Applied Sciences of Lyon (INSA, France). After a few years in food and beverage and diagnostic, she started her career at our company in 2006 as a technical support engineer before moving to downstream field marketing with local, then global responsibilities. She then specialized in downstream systems and operations, and is her current role focuses on novel modalities such as ADC.
June Hwang
Merck
Senior Modality Leader for Advanced Antibodies
June Hwang, Senior Modality Leader for Advanced Antibodies in Life Science Process Solutions, has over 16 years in life sciences and biopharma. With over 13 years of experience, she specializes in upstream/downstream processing, single-use systems, and continuous bioprocessing. She leads solutions for ADCs across APAC (excluding China), focusing on process efficiency and customer needs. June previously served as Global Go-to-Market Lead for Clarification, Upstream Systems, and Mixers portfolios.
Pharma and biopharma manufacturing
- Antibody drug conjugate manufacturing
Duration:1h
Language:English
Session 1:Tue, October 20, 2026 3:00 PM SGT